TD SELL $XENE at 9.98, Supp 8.96 Resis 10.08 R13 HiLo 43% T1Y 17 none fwdPE -5.7 DIV N/A #Xenon Phar #stocks #trading #finance #market

2019-05-30
94 Views

TD SELL detected for XENE (Xenon Pharmaceutical) at the close price of 9.98 with a support level at 8.96 and a resistance at 10.08, providing an opportunity for a 13 % return. Trading at a 43 % level between the 52week high 15.92 and 52 week low 5.41. The average analyst 1-year target price is 17.0 with an average none and a score of 0.0.

TD Sell
13 %
XENE
9.98
Xenon Pharmaceutical
HiLo
43.5 %
Support
8.96
Resistance
10.08
50DMA
9.54
200DMA
9.59
52week high
15.92
52week low
5.41
10DMA
9.68
20DMA
9.43
100 Mean
8.93
Volume
45794
AvgDayVol
97303
MarketCap
257214528
EBITDA
-41453000
Revenue
0
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#GoldenCross $G1A.DE at 26.67 R7  HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP  #DAX #Aktien #Boerse #stocks
Bull, Europe, Germany
13 views
Bull, Europe, Germany
13 views

#GoldenCross $G1A.DE at 26.67 R7 HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP #DAX #Aktien #Boerse #stocks

Andreas Aigner - 2019-09-19

Golden Cross detected for G1A.DE (GEA GROUP AG) at the close price of 26.67. Trading at a 54 % level…

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9  HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading
Bear, Europe, Financial Services
9 views
Bear, Europe, Financial Services
9 views

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9 HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading

Andreas Aigner - 2019-09-19

TD SELL detected for DLG.L (DIRECT LINE INSURANC) at the close price of 305.40 with a support level at 279.90…

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.